PROTEONOMIX, INC. (OTC BB: PROT.OB), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced on August 6, that it has formed a new subsidiary called X Gen Medical LLC, a Nevis Virgin Island entity. X Gen Medical has been established with the intention of conducting business in the global medical marketplace. Proteonomix plans on utilizing X Gen Medical to serve as a platform for joint ventures with medical facilities worldwide. It is anticipated that new relationships formed with X Gen Medical will create medical facilities capable of not just attracting treatments locally, but also acting as hubs for medical tourism. Medical tourism is constantly on the rise and anticipated to continue to grow substantially due to current high costs of health care for certain procedures and improvements in both technology and standards of care in many countries.
Mr. Michael Cohen, Chairman and CEO of Proteonomix, stated, �We have been in negotiations with several groups, specifically in the Middle East and Europe, to establish Proteonomix Regenerative Translational Medicine Institute (�PRTMI�) medical facilities in those regions. The negotiations have reached the level whereby the establishment of a separate subsidiary, X Gen Medical LLC., was essential in order to allow Proteonomix to properly enter these global markets with the intention of soliciting business through our proprietary PRTMI model. We anticipate closing on some of these negotiations in the near future, which we anticipate will include the necessary funding required to firmly establish X Gen Medical as a PRTMI provider.�
It may be time to think more positively about the exciting innovations that are about to take place in eradicating diseases.
PROTEONOMIX is focused on the concept of �Curing� diseases through Stem Cell regenerative therapy, the future is now!
More about PROT at: www.proteonomix.com
PMC-Sierra, Inc. (NASDAQ:PMCS) engages in the design, development, marketing, and support of semiconductor solutions for the enterprise infrastructure and communications infrastructure markets.
Its products include controllers based on Fibre Channel, Serial Attached SCSI, and Serial ATA that enable the development of external and server-attached storage systems; framers and mappers, which convert the data into a format for transmission in the network before the data is sent to the next destination; line interface units that transmit and receive signals over a physical medium, such as wire, cable, or fiber; and microprocessor-based system-on-chips, which perform the high-speed computations that help in identifying and controlling the flow of signals and data in various network equipment used in the communications, storage, and enterprise markets.
More about PMCS at: www.pmc-sierra.com
Amkor Technology, Inc. (Nasdaq: AMKR) recently announced that Joanne Solomon, the company�s executive vice president and chief financial officer, will participate in the 2010 Deutsche Bank Technology Conference in San Francisco, CA, on Wednesday, September 15, 2010. The presentation is scheduled to begin at 2:20 P.M. (PDT).
An audio-only webcast of the presentation will be made available, both live and by replay, on the Investor Relations section of the company�s website. In accordance with company policy, Amkor will not update, reaffirm or otherwise comment on any prior financial guidance during this conference. Amkor�s financial guidance for the quarter is effective only on the date given.
More about AMKR at: www.amkor.com
No comments:
Post a Comment